In one paragraphArticle in Neurology(R) neuroimmunology & neuroinflammation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Tolulope O AmiolaFrom the Departments of Neurology (T.O.A., U.O., M.D.G.) and Neuropathology (H.R.), VCU School of Medicine, Richmond, VA; Department of Neurology (S.D.N.), Johns Hopkins Hospital, Baltimore, MD; Department of Neurosciences (J.G.), University of California at San Diego, La Jolla and Department of Neurology (S.S.Z.), Program in Immunology, University of California at San Francisco.ORCID 0000-0002-9768-9275 Unsong OhFrom the Departments of Neurology (T.O.A., U.O., M.D.G.) and Neuropathology (H.R.), VCU School of Medicine, Richmond, VA; Department of Neurology (S.D.N.), Johns Hopkins Hospital, Baltimore, MD; Department of Neurosciences (J.G.), University of California at San Diego, La Jolla and Department of Neurology (S.S.Z.), Program in Immunology, University of California at San Francisco.ORCID 0000-0002-1762-5299 Hope RichardFrom the Departments of Neurology (T.O.A., U.O., M.D.G.) and Neuropathology (H.R.), VCU School of Medicine, Richmond, VA; Department of Neurology (S.D.N.), Johns Hopkins Hospital, Baltimore, MD; Department of Neurosciences (J.G.), University of California at San Diego, La Jolla and Department of Neurology (S.S.Z.), Program in Immunology, University of California at San Francisco.ORCID 0000-0002-5956-0585 Scott D NewsomeFrom the Departments of Neurology (T.O.A., U.O., M.D.G.) and Neuropathology (H.R.), VCU School of Medicine, Richmond, VA; Department of Neurology (S.D.N.), Johns Hopkins Hospital, Baltimore, MD; Department of Neurosciences (J.G.), University of California at San Diego, La Jolla and Department of Neurology (S.S.Z.), Program in Immunology, University of California at San Francisco.ORCID 0000-0002-5284-4681 Jennifer GravesFrom the Departments of Neurology (T.O.A., U.O., M.D.G.) and Neuropathology (H.R.), VCU School of Medicine, Richmond, VA; Department of Neurology (S.D.N.), Johns Hopkins Hospital, Baltimore, MD; Department of Neurosciences (J.G.), University of California at San Diego, La Jolla and Department of Neurology (S.S.Z.), Program in Immunology, University of California at San Francisco.ORCID 0000-0003-1539-1940 Scott S ZamvilFrom the Departments of Neurology (T.O.A., U.O., M.D.G.) and Neuropathology (H.R.), VCU School of Medicine, Richmond, VA; Department of Neurology (S.D.N.), Johns Hopkins Hospital, Baltimore, MD; Department of Neurosciences (J.G.), University of California at San Diego, La Jolla and Department of Neurology (S.S.Z.), Program in Immunology, University of California at San Francisco.ORCID 0000-0003-2720-9915 Myla D GoldmanFrom the Departments of Neurology (T.O.A., U.O., M.D.G.) and Neuropathology (H.R.), VCU School of Medicine, Richmond, VA; Department of Neurology (S.D.N.), Johns Hopkins Hospital, Baltimore, MD; Department of Neurosciences (J.G.), University of California at San Diego, La Jolla and Department of Neurology (S.S.Z.), Program in Immunology, University of California at San Francisco.ORCID 0000-0002-5675-945X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
A 42-year-old woman and active cocaine user complained of subacutely worsening blurred vision and imbalance. Examination of the brain MRI showed rapidly expanding white matter lesions. Brain biopsy was consistent with inflammatory demyelination. Given an unusual presentation and a history of cocaine use, a broad differential diagnosis was considered including neurologic toxidromes.
Indexed as
CocaineMultiple SclerosisWhite MatterAdultFemaleHumansMagnetic Resonance ImagingNeuroimagingCocaine
Identifiers
PMID38285968
PMCPMC11073887
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390